Episodes
-
In this episode Dr Casy Calver talks to Dr Katie Witkiewitz. Dr Witkiewitz talks about her experience as an editor and specifically about desk rejection - sometimes called reject without review. She talks about the many reasons that articles are rejected without going to peer-review. These can include there being too many similar studies already in the journal, page limits and articles being outside the scope of the journal. There are also avoidable issues of quality. Dr Witkiewitz then gives her top tips for how best to avoid (and cope with) desk rejection.
"You know, I think in the stress and strain of getting a paper out you don't re-read it in its entirety often, right? It's been through a lot of edits, maybe you were just frantically getting it in the journal format in the last minute you made some changes to get it in under word-count. But you didn't take a step back and re-read it."Dr Katie Witkiewitz is a Distinguished Professor of Psychology and the Director of the Center on Alcohol Substance Use and Addiction at the university of New Mexico as well as the Editor of the journal Psychology and Addictive Behaviours.
The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this episode of Publishing Addiction Science, Dr Casy Calver talks to Professor Paul Dietze about common submission errors. They talk about how to avoid desk-rejection, the importance of understanding the scope of the journal to which you submit, the importance of following instructions to authors. Many journals have differing requirements and this can change between internationally focused journals or those with a more regional remit. They also talk about the importance of using person-first and non-stigmatising language.
Paul Dietze is Executive Editor of the Drug and Alcohol Review journal and an ISAJE board member.
Whatever you do don't annoy the editor. And one way to annoy an editor is to send in a crappy abstract or a misleading title, so that's a really good starting point.Paul Dietze is Professor at the National Drug Research Institute and co-Director of the Disease Elimination Program at the Burnet Institute in Melbourne, Australia. He is Executive Editor of Drug and Alcohol Review and was previously an Associate Editor of the International Journal of Drug Policy and Deputy Editor of Drug and Alcohol Review. As Executive Editor, he manages all submissions to Drug and Alcohol Review. He has published over 350 journal articles and numerous book chapters spanning the epidemiology of alcohol and other drug use and related harms through to clinical intervention studies. He has a strong interest in developing early career researchers and responding to predatory publishers and journals.
The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
Episodes manquant?
-
In this episode, Casy and Rob talk to Leila Moore, the Director of Open Access policy at Wiley. Leila covers the history, principles and processes relating to open access as well as describing the mechanisms by which research is made freely available for people who want to access it. Leila explains how open access publishing can increase accessibility and ensure research reaches a more diverse readership meaning that people who previously could not access research findings now can. Leila also explains APCs (article processing charges) and transformational agreements.
"Open access increases opportunities for collaboration reduces duplication, speeds up groundbreaking discoveries and enables more people than ever before to access this research. Whether that's a patient looking for information on illness, a teacher looking for new ways to work with students or a researcher who discovers the next great opportunity for collaboration."The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this episode, Casy and Rob talk to Thomas Broomfield from Wiley about the impact factor. Thomas covers everything from how it is calculated, what it means, its limitations as well as discussing alternative ways to rate or assess a journal's output. Thomas covers hidden, linked and un-linked citations, describes how to get an impact factor of 254 and explains that sometimes people cite a journal cover image (whilst remaining uncertain about why).
Thomas explains the JIF, the JCR, Web of Science, citation databases, DORA, ESCI, Clarivate, Alt Metrics and how they all relate to That Number.
"The calculation itself has stayed pretty constant..... what has really changed is the underlying database, what's included, what isn't and what data is being used to make certain decisions."Thomas is a Senior Market Analyst at Wiley publishers. This conversation was recorded in February 2023.
The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this episode of Publishing Addiction Science, Dr Casy Calver talks to Prof. Bill Stoops about how to choose a journal in which to publish. Casy and Bill talk about how to define your audience so you can publish in a journal where your audience will find your research. Bill talks about his experiences as an author in addition to his views as a journal editor. He gives advice on how to approach journals to check whether an article is likely to be a good fit and therefore a good home for your hard won research paper. They also identify some red flags for identifying predatory journals.
Professor Bill Stoops is Editor for the journal Experimental and Clinical Psychopharmacology.
"One thing I really do think about... is where it's indexed. So, is it going to get caught in a broad search? Is it going to get caught in PubMed, is it going to get caught in PsychInfo?"The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this episode Dr Casy Calver talks to Professor Richard Pates, who is an ISAJE board member and Editor-in-Chief of the journal Substance Use.
Richard talks about how to decide on journal manuscript authorship and the best time to discuss those roles in the writing process. Richard discusses some of the experiences he had as a junior researcher, and how they have informed his approach to authorship. He also covers his mentorship of early career researchers, and in his role as an editor of an academic journal.
"You've got to make a significant contribution, not because you're in a certain position or not because you're someone husband or wide, but because you've made a significant contribution to that paper"Richard is one of the founding members of ISAJE.
The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
Welcome to Publishing Addiction Science - a podcast for the perplexed. This series is for anyone working in addiction research who is trying to navigate the choppy waters of academic publishing.
We will feature interviews with Editors-in-Chief of some of the leading academic addictions journals. They will tell you how to improve your chances of being published and how to avoid common errors.
Dr Casy Calver is the Executive Officer of ISAJE, the International Society of Addiction Journal Editors, Editorial Director at the Grayken Center for Addiction at Boston Medical Center, and managing editor of the journal Addiction Science & Clinical Practice.
Dr Rob Calder is Head of Communications and Operations at the SSA, the Society for the Study of Addiction.
The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of ISAJE or the SSA.
ISAJE and the SSA do not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this episode, Merve Mollaahmetoglu, Ben Scher, Zoe Swithenbank and Rob Calder talk live from the poster room (with mocktails) about their thoughts on day 1 of the SSA Annual Conference in 2023. They cover research into substance use among refugees, heroin assisted treatment, gambling research and ADHD and addiction.
Apologies for a few sound quality issues in this episode.
The opinions expressed in this podcast reflect the views of the presenters and interviewees and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this episode, Rob Calder talks to the SSA's Fred Yates Prize winner Ebtesam Saleh. They discuss her work researching substance use among refugees and immigrant populations as well as her career going from a pharmacist in Yemen to becoming an award-winning researcher. This interview was conducted in September 2023 ahead of Ebtesam's Fred Yates Prize presentation and at the SSA's Annual Conference in Newcastle on 9 and 10 November 2023.
"Migrants lost their safe zone at the beginning. Completely. In terms of their land, their own families and loved ones. So they are struggling to start a new life but at the same time are living in a parallel world in their painful memories."The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
Professor Wim van den Brink will be giving the Society Lecture at the SSA's 2023 Annual Conference. In this special episode of the Addictions Edited podcast, he talks to Rob Calder about attention deficit hyperactivity disorder (ADHD) and addiction.
âIf we want to prevent substance use disorders in patients with ADHD, we have to start early.â
In an exclusive interview for the Addictions Edited podcast, Wim says that he hopes to use his talk at the SSA conference to deliver a few key messages: firstly, that ADHD is very common in patients with addiction â perhaps one in four will have adult ADHD; secondly, that the overlap or comorbidity could be attributed to a number of things â from neurobiological and psychological factors, to genetics and the environment; and thirdly, that establishing the respective weight of these contributing factors is important for prevention and treatment â for example, in determining whether pharmacological treatments and neuromodulation could offer more promise than, say, psychotherapies.
The opinions expressed in this post reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the authorâs academic institution.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this podcast Rob Calder talks to Dr Karen Berry about the latest research in treatment for benzodiazepine use. They discuss the recent rise of illicit and prescribed benzodiazepines in recent years; the difference between prescribed and street drugs, and how drugs prescribed in the US are making their way onto illicit markets.
âThey've become a rising issue both as illicit benzos like etizolam...And then also people are using prescribed diazepam, but it's not prescribed to them. So they're able to get hold of proper diazepam but on the street.âKaren talks about her latest research project looking at prescribing regimes for people who want to address benzodiazepine use. She discusses why the team recruited people who use both benzodiazepines and opiates and the implications of their research for drug overdose deaths.
Karen also talks about some of the issues raised by the project about gaining consent from participants and how that consent can change throughout an intervention and across different appointments and research team members.
Dr Karen Berry is a research fellow at the University of Stirling employed by the Salvation Army Centre for Addiction and Substance Research.
The opinions expressed in this podcast reflect the views of the guest(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
Dr Gillian Shorter talks to podcast host Rob Calder about her research into drug consumption rooms, including how they work, why she doesnât believe they are controversial interventions, and what the evidence base suggests about their effectiveness.
âThe big thing that always comes up though is âwhy are there no randomised controlled trials?â It comes up every time and it's a very simple answer. We know these places save lives. We have an evidence base across multiple countries to show that it does. So, it's not ethical to randomise one area to have a drug consumption room and one not to.â
She also explains the ethos behind her decision to research brief alcohol interventions and safer consumption facilities â two seemingly disparate types of substance use intervention â as well as her experience developing core outcome sets and her role with the Drugs and Alcohol Research Network (DARN).
Papers mentioned in the podcast include the following:
The effect of question order on outcomes in the orbital core outcome set for alcohol brief interventions among online help-seekers (QOBCOS): Findings from a randomised factorial trial. By Marcus Bendtsen and colleagues. Published in Digital Health (2023).Overdose prevention centres in the UK. By Adam Holland and colleagues. Published in The Lancet (2022).The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation. By Gillian Shorter and colleagues. Published in the International Journal of Drug Policy (2022).Prioritizing variables for evaluating the efficacy and effectiveness of brief interventions for reducing alcohol consumption: A Latin American perspective. By Marcela Tiburcio and colleagues. Published in the Journal of Studies on Alcohol and Drugs (2022).The âOutcome Reporting in Brief Intervention Trials: Alcoholâ (ORBITAL) core outcome set: International consensus on outcomes to measure in efficacy and effectiveness trials of alcohol brief interventions. By Gillian Shorter and colleagues. Published in the Journal of Studies on Alcohol and Drugs (2021).Prioritization of outcomes in efficacy and effectiveness of alcohol brief intervention trials: International multi-stakeholder e-Delphi consensus study to inform a core outcome set. By Gillian Shorter and colleagues. Published in the Journal of Studies on Alcohol and Drugs (2019).Gillian Shorterâs work on core outcome sets for alcohol brief interventions (ORBITAL project) was funded by Alcohol Change/Alcohol Research UK (Research Innovation Grant Number: R2016/04) and her work on drug consumption rooms is supported by a grant from National Institutes of Health Research (NIHR204582: co-PI Professor Alex Stevens and Dr Gillian Shorter).
~
The opinions expressed in this podcast reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the authorâs academic institution.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
~
Hosted on Acast. See acast.com/privacy for more information.
-
Dr Nicky Kalk and Dr Caroline Copeland talk about their research into methadone- and buprenorphine-related deaths during the COVID-19 pandemic. Nicky and Caroline talk me through the number of deaths they would expect to see in an average year and the differences between that and what happened during COVID-19-related lockdowns. Nicky tells us how the UK has influenced the US response to Hurricane Katrina whereby people were given larger amounts of opioid agonist medication than they were used to.
âInstead of most people in early treatment being directly supervised consumptionâŠ.the majority of people were converted to 2 weeks' worth of take-home supply.âCaroline and Nicky then talk about possible explanations for the overdose rates found among people not in treatment, indicating the protective impact that treatment can have for people. They also talk about how their study challenged their thinking about the impact of diversion on the risk of overdose. Finally, they talk about the overall impact that the COVID-19 pandemic had on people seeking and accessing treatment.
âThere are things that make us sustain a behaviour and things that make us think that itâs time to make a change. And I suppose something as catastrophic as a lock-down with all the potential impacts that that might have on support or access to one's drug of choice, maybe changed the equation for people.âThe opinions expressed in this podcast reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the authorâs academic institution.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
This podcast is for anyone who wants to understand the experience of and feelings associated with relapse.
Dr Maike Klein talks about her qualitative research into relapse, and about how different people conceptualise and perceive relapse. She talks about how, for some, it is a process rather than an event, whereas for others it is a shocking and immediate experience. There are also elements of self-actualisation and learning that can follow a relapse - as well as the real fear that relapse can cause.
Maike talks about the feelings of powerlessness that can accompany relapse as well as the importance that some people place on gaining trust in themselves. Looking further into the language of relapse, Maike explores how relapse is sometimes seen as a location by some people and the implications this has for working with substance use.
Maike also spoke to people who work in addiction treatment services about their experiences working with people who relapse and of second-hand trauma.
âHow does it feel like for a therapist to witness their clientâs relapse and does that impact the way that they approach their therapeutic work?ââIt feels almost like torture in their minds of having that internal fragmentation thatâs almost more difficult than the relapse experience itselfâ.The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
-
In this two-part podcast the SSA's Rob Calder explores autism and addiction. He talks to Professors Julia Sinclair and Sam Chamberlain, Dr Janine Robinson and Chris Torry from the SABAA: Substance use, Alcohol and Behavioural addictions in Autism project thatâs been funded by the SSA.
In this second episode we explore treatment, policy and future research in relation to autism and addiction. We start by talking about the importance of co-producing publicity materials for addiction treatment services using universal design principles. Personalisation is always important and ever more so when working with autistic people, thus underlining the importance of involving autistic people in service design.
We talk about the experience and expectations that autistic people might have when attending addiction treatment services, and why retention may not mean what you think it means. We then talk about the work of the SABAA project in identifying the gaps in our understanding of autism and addiction. The team talks about conducting a Delphi process and working out what the priorities are for policy, practice and research.
They then discuss some of the problems with funding something that is often considered a niche issue within autism and addiction fields.
âThings that are autism friendly will also be good quality for other people⊠By being autism friendly [promotion materials] are more likely to be more accessible by other people tooâ - Professor Julia SinclairâWith CBT you need to rate things, and some [autistic] people say to me âI donât like rating things. I prefer having colour, blue means this, yellow means thatâ. Theyâre different things that mean something to themâ - Dr Janine RobinsonâThe NHS has really changed in that sense, thereâs still more work to do, but weâre seeing lived experience become part of the clinical models to a greater extent which is a good thing.â - Professor Sam ChamberlainâThe neurology and basis of autism are poorly understood and then you have the neurological factors of addiction and compulsion, and trying to reconcile and differentiate those things is a really complex questionâ - Chris TorryProfessor Julia Sinclair
Julia Sinclair is Professor of Addiction Psychiatry in the Faculty of Medicine at the University of Southampton, and honorary consultant in alcohol liaison at University Hospital Southampton.
Dr Janine Robinson
Janine Robinson is a Consultant Clinical Psychologist and a specialist in the field of autism in adults. She completed her DClinPsy at the Institute of Psychiatry, Kingâs College, London in 2000.
Professor Sam Chamberlain
Sam Chamberlain is Professor of Psychiatry at the University of Southampton, and Honorary Consultant Psychiatrist at Southern Health NHS Foundation Trust.
Chris Torry
Chris Torry is autistic and has worked in addiction treatment services for many years. He is part of the SABAA project
The opinions expressed in this post reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA. The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Hosted on Acast. See acast.com/privacy for more information.
-
In this two-part podcast, the SSA's Rob Calder explores autism and addiction. He talks to Professors Julia Sinclair and Sam Chamberlain, Dr Janine Robinson and Chris Torry from the SABAA: Substance use, Alcohol and Behavioural addictions in Autism project thatâs been funded by the SSA.
In this first episode, we look at how symptoms of behavioural and substance addictions can overlap with autism and how this can complicate diagnoses for both. We explore some of the causes of substance use that are particular to autism, whilst looking at how autistic people often use substances in ways that might make them more vulnerable to addiction. This includes issues of using alcohol to address social anxiety. We also ask why some treatment services can be difficult for autistic people to access and how treatment services might start to address these issues.
âMaybe our diagnostic tools need to consider more carefully that fine line between when something maybe becomes a behavioural addiction versus something that perhaps is a core part of autismâ - Dr Janine RobinsonâWhat we have here is several spectrum disorders, peopleâs substance use might be on a spectrum, alcohol use might be on a spectrum and their manifestation of autism is also on a spectrum.â - Professor Julia SinclairâTreatment structured around groupwork can be really difficult for some people because itâs overwhelming or stressful. The sensory environment can be really unpleasant lots of fluorescent lights and noise and lots of people interacting in sometimes intense and difficult to process ways.â - Chris TorryâOne issue is that many clinicians may not be familiar with autism. Other clinicians, for example, who are familiar with autism may have no training in behavioural addictions or substance use disorders.â - Professor Sam ChamberlainProfessor Julia Sinclair
Julia Sinclair is Professor of Addiction Psychiatry in the Faculty of Medicine at the University of Southampton, and honorary consultant in alcohol liaison at University Hospital Southampton.
Dr Janine Robinson
Janine Robinson is a Consultant Clinical Psychologist and a specialist in the field of autism in adults. She completed her DClinPsy at the Institute of Psychiatry, Kingâs College, London in 2000.
Professor Sam Chamberlain
Sam Chamberlain is Professor of Psychiatry at the University of Southampton, and Honorary Consultant Psychiatrist at Southern Health NHS Foundation Trust.
Chris Torry
Chris Torry is autistic and has worked in addiction treatment services for many years. He is part of the SABAA project.
The opinions expressed in this post reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the authorâs academic institution. The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Hosted on Acast. See acast.com/privacy for more information.
-
In this SSA podcast, Alexis Roth gives us a preview of her talk at our 2022 Annual Conference. Dr Roth talks about the UnityPhilly app and wearable and other technologies that are being developed to help prevent opiate overdoses.
Alexis talks about the consumer led way in which the app was designed as well as her experiences working with technology companies:
ââŠthey had already built the sort of âUber-for-overdoseâ component where itâs like âYou signal, we alert, we can geofence these thingsâ. That part was there. But then trying to work with them to customise it, to make it simpler, more streamlined, more like what you might find on a game kind of app was a challenge. And something we are still working towardsâShe also talks about developing a wearable biosensor that fits in peopleâs underwear that monitors respiratory rate. As well as the next steps in developing technology to identify an overdose and remotely administer naloxone.
"Technology, when done in consultation with folks who would be the end users of these products and developed to respond to their concerns, their needs .... have a lot of potential."Hosted on Acast. See acast.com/privacy for more information.
-
In this episode, Dr Claire Garnett, winner of the SSAâs Fred Yates prize 2022, talks about her research and career. She focuses on her work at UCL developing the Drink Less app for reducing alcohol related harms and drinking. Claire also talks about how the team developed an app that was based on theoretical models of change and on health psychology and behavioural science principles.
âMy career thus far has been: If Iâve really enjoyed doing something and found it interesting, Iâve kept goingâClaire also talks about her work on user testing and the lengthy process of making sure that health related apps work how they are intended before then evaluating them.
âWe thought weâd created the best app â I was so proud of it. We did those first ones and no one had any idea what to do when they arrived at the landing page [...] And it was so obvious to us because weâd been so involved with it, and it really highlighted the importance of [user testing].âClaire also talks about the impact of being endorsed by a certain 51-year-old celebrityâŠ
âI was like âeveryone knows who Adrian Childs isâ, and somebody went âno they donâtâ [âŠ] so we need to explain from a scientific perspective who actually is this person and why might it matter that he spoke about the app.âHosted on Acast. See acast.com/privacy for more information.
-
Rob talks to WDP about the challenges and rewards of running an IPS employment support programme.
In this episode of Addictions Edited, Rob looks at how addiction treatment services can help people to find and keep employment. Recorded on 20 March 2022, Rob met three people who work in WDPâs Individual Placement and Support service (IPS Into Work); Rebecca Odedra, Harj Bansil and Claire Bowey. They each talked about finding jobs, the range of jobs they work with and how they deal with potentially stigmatising views when talking to employers. As well as the challenges, they also talk about how rewarding their work can be when helping people in their recovery.
Rebecca discusses how IPS was adapted from mental health settings, how it is evaluated and their experiences of fidelity rating.
âYouâve got people who may have been unemployed for 10 sometimes 20 years, so that is a huge step for them and itâs such an achievement and itâs just nice to be a part of that and help people realise their goalsâClaire Bowey
âWhat really appealed to me about the IPS model, was that it did not discriminate, it wasnât someone telling service users that you have to be well to be working, it was very much based on their motivation and then developing the right support around them to foster successful outcomesâHarj Bansil
Useful links:
About IPS: https://ipsgrow.org.uk/what-is-ips/WDP website: https://www.wdp.org.uk/IPS Into Work: https://www.wdp.org.uk/employment-supportIPS Into Work Impact Report 2019-2021: https://www.wdp.org.uk/ips-impact-reportHosted on Acast. See acast.com/privacy for more information.
-
For this special episode, Rob visits a London treatment service to talk to Martin McCusker from Lambeth Service User Council and Dr Martin Sefranek a substance misuse worker and researcher and Dr Rebecca McDonald an addictions researcher who joins them on zoom from Oslo.
The podcast covers several key issues relating to naloxone, including how it works, how to administer it, legal implications and the latest research. They talk about the role of naloxone in reducing drug-related deaths in the UK and the implications for drug policy.
They also discuss how to encourage people who use drugs to carry naloxone and the reasons why some people might not. Martin McCusker and Martin Sefranek talk about training people to use naloxone. And in particular their work with family and parents.
âYou always call the ambulance, but then âŠ. you are counting the minutes or seconds yeah, but if you have naloxone you can do something more. And I think for these parents it was important to know that this is something they can do.â â Martin SefranekâWeâve had really positive interactions between people and police âŠwhere theyâve been stopped and searched and itâs been a tense situation but then the naloxone is found and the whole vibe of the search changes.â â Martin McCuskerâThere is the estimate that two-thirds of overdoses could be prevented, but this very much relies on people not using on their own.â - Rebecca McDonaldHosted on Acast. See acast.com/privacy for more information.
- Montre plus
